* BIO-Key International Inc BKYI.OQ reported a quarterly
adjusted loss of 16 cents per share for the quarter ended in
June. The lone analyst forecast for the quarter was for a loss
of 23 cents per share.
* Revenue fell 1% to $1.93 million from a year ago; analysts
expected $2.30 million.
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* BIO-Key International Inc shares had fallen by 7.6% this
quarter and gained 18.8% so far this year.
* The company reported a quarterly loss of $1.42 million.
* Wall Street's median 12-month price target for BIO-Key
International Inc is $2.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
August 14 at 11:22 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 -0.23 -0.16 Beat
Mar. 31 2023 -0.27 -0.08 Beat
Dec. 31 2022 -0.27 -0.40 Missed
Sep. 30 2022 -0.16 -0.29 Missed